PDT Partners’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-71,810
| Closed | -$981K | – | 772 |
|
|
2022
Q3 | $981K | Sell |
71,810
-16,407
| -19% | -$224K | 0.15% | 224 |
|
|
2022
Q2 | $1.62M | Buy |
88,217
+150
| +0.2% | +$2.75K | 0.14% | 227 |
|
|
2022
Q1 | $1.42M | Buy |
88,067
+67,007
| +318% | +$1.08M | 0.12% | 261 |
|
|
2021
Q4 | $295K | Buy |
+21,060
| New | +$295K | 0.02% | 671 |
|
|
2020
Q3 | – | Sell |
-11,334
| Closed | -$185K | – | 793 |
|
|
2020
Q2 | $185K | Sell |
11,334
-43,067
| -79% | -$703K | 0.01% | 601 |
|
|
2020
Q1 | $541K | Buy |
54,401
+10,836
| +25% | +$108K | 0.04% | 352 |
|
|
2019
Q4 | $599K | Buy |
43,565
+16,724
| +62% | +$230K | 0.04% | 378 |
|
|
2019
Q3 | $407K | Buy |
26,841
+5,841
| +28% | +$88.6K | 0.02% | 354 |
|
|
2019
Q2 | $413K | Buy |
+21,000
| New | +$413K | 0.02% | 315 |
|